Point72 Asset Management
FLNA

Point72 Asset Management’s Filana Therapeutics FLNA Stock Holding History

Point72 Asset Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.1K Sell
39,121
-260,458
-87% -$536K ﹤0.01% 3645
2025
Q4 		$593K Buy
+299,579
New +$959K ﹤0.01% 3155
2020
Q4 		– Sell
-125,000
Closed -$1.44M – 1106
2020
Q3 		$1.44M Buy
+125,000
New +$564K 0.01% 741

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Point72 Asset Management's FLNA Position: Q1 2026 in Review

Point72 Asset Management reduced its Filana Therapeutics (FLNA) stake by 87% in Q1 2026, selling an estimated $536K and leaving 39,121 shares worth $66.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3645.

Point72 Asset Management first reported a position in FLNA in Q3 2020 and has held it in 3 quarters since. The position peaked at $1.44M in Q3 2020. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Point72 Asset Management held 39,121 shares of Filana Therapeutics worth $66.1K as of Q1 2026.
  • Point72 Asset Management sold 260,458 Filana Therapeutics shares in Q1 2026, an estimated $536K.
  • Filana Therapeutics made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3645 holding.
  • Point72 Asset Management first reported a position in Filana Therapeutics in Q3 2020 and has held it in 3 quarters since.
  • Point72 Asset Management's Filana Therapeutics position peaked at $1.44M in Q3 2020.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.